We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$39.5M
Cap. Flow
-$1.25M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.84%
Holding
1,111
New
66
Increased
187
Reduced
301
Closed
121

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$1.88M
2
IBIT icon
iShares Bitcoin Trust
IBIT
+$1.45M
3
ETHA
iShares Ethereum Trust ETF
ETHA
+$606K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$330K
5
GRNY
FundStrat Granny Shots US Large Cap ETF
GRNY
+$324K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$2.11M
2
AAPL icon
Apple
AAPL
+$847K
3
XLG icon
Invesco S&P 500 Top 50 ETF
XLG
+$325K
4
RDVI icon
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
+$285K
5
MSFT icon
Microsoft
MSFT
+$235K

Sector Composition

Rank Sector Weight
1 Technology 27.84%
2 Financials 15.73%
3 Industrials 12.04%
4 Real Estate 10.42%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRN
926
Amarin Corp
AMRN
$303M
$195 ﹤0.01%
12
-1
-8% -$11
PLRX icon
927
Pliant Therapeutics
PLRX
$65M
$194 ﹤0.01%
167
– –
CAN
928
Canaan Creative
CAN
$159M
$189 ﹤0.01%
305
– –
GLDG
929
GoldMining Inc
GLDG
$219M
$144 ﹤0.01%
200
– –
EDIT icon
930
Editas Medicine
EDIT
$442M
$134 ﹤0.01%
61
– –
OWL icon
931
Blue Owl Capital
OWL
$18.5B
$118 ﹤0.01%
6
– –
TVRD
932
Tvardi Therapeutics
TVRD
$23.4M
$93 ﹤0.01%
+4
New +$95
SCHG icon
933
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$88 ﹤0.01%
3
– –
ACCO icon
934
Acco Brands
ACCO
$407M
$82 ﹤0.01%
23
– –
CSCI
935
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$75 ﹤0.01%
22
– –
AKTX
936
Akari Therapeutics
AKTX
$12.3M
$59 ﹤0.01%
1
– –
CORT icon
937
Corcept Therapeutics
CORT
$12B
$54 ﹤0.01%
+1
New +$73
CYBR
938
DELISTED
CyberArk
CYBR
– –
0
– –
RMR icon
939
The RMR Group
RMR
$332M
$49 ﹤0.01%
3
– –
DG icon
940
Dollar General
DG
$27.9B
– –
0
– –
YARW
941
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$41 ﹤0.01%
1
– –
TRI icon
942
Thomson Reuters
TRI
$44.1B
– –
0
– –
SWK icon
943
Stanley Black & Decker
SWK
$15.7B
$34 ﹤0.01%
1
– –
BIDU icon
944
Baidu
BIDU
$37.2B
– –
0
– –
ODDS icon
945
Pacer BlueStar Digital Entertainment ETF
ODDS
$4.07M
$32 ﹤0.01%
1
– –
SBRA icon
946
Sabra Healthcare REIT
SBRA
$5.37B
$32 ﹤0.01%
+2
New +$35
BB icon
947
BlackBerry
BB
$5.26B
$31 ﹤0.01%
+7
New +$26
IONS icon
948
Ionis Pharmaceuticals
IONS
$9.4B
$30 ﹤0.01%
1
-39
-98% -$1.28K
VFC icon
949
VF Corp
VFC
$5.89B
$30 ﹤0.01%
3
– –
WIT icon
950
Wipro
WIT
$20B
$26 ﹤0.01%
+9
New +$26
36 37
38
39 40

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Truvestments Capital held 1,111 positions worth $500M, up 8.6% from $461M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital's Q2 2025 filing shows 66 new, 187 increased, 301 reduced and 121 closed positions. Its largest new stake was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K. The largest sale was Wells Fargo, an estimated $2.11M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

  • Truvestments Capital's largest Q2 2025 buy was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K.
  • Truvestments Capital added most to Strategy Inc in Q2 2025, an estimated $1.88M increase.
  • Truvestments Capital's biggest Q2 2025 reduction was Wells Fargo, cutting an estimated $2.11M.
  • Truvestments Capital fully exited Patterson Companies, Inc. in Q2 2025, selling an estimated $141K.
  • Truvestments Capital's ten largest holdings make up 27% of its $500M portfolio in Q2 2025.
  • Truvestments Capital opened 66 new positions and closed 121 in Q2 2025.
  • Truvestments Capital's portfolio value rose 8.6% quarter-over-quarter to $500M.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.